Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-971 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2474-20 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2001-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2398a43766e3a69c9cc20c955ee75507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9e31f61024f23416fdcb53c0c71ff09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c90650b84b414e8805b7ffe9c11406f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b0c3eb80d5cae03ba5067a96f41085b |
publicationDate |
2003-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003215875-A1 |
titleOfInvention |
Screening process for atopic dermatitis |
abstract |
The present invention provides a process of screening patients for atopic dermatitis. The process includes the step of determining, in sera of the patient, the presence of antibodies against nuclear antigens such as transcription co-activator p75, wherein the presence of such antibodies indicates atopic dermatitis. The screening process can be used to detect atopic dermatitis in patients suffering from other conditions such as asthma or interstitial cystitis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008131902-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009053712-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168393-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005053637-A1 |
priorityDate |
2000-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |